Dr. Anil Modak
Expert in Stable Isotope Breath Tests and Consultant to Leading Life Sciences and Technology Companies
Anil Modak, PhD was till recently the Associate Director of Medical Products Research & Development at Cambridge Isotope Laboratories Inc.in Tewksbury, MA in the US. He has been involved in the design, research and development of novel non invasive breath tests for personalized medicine using stable isotope substrates for the monitoring of disease severity/toxicity and the evaluation of drug metabolizing enzyme activity. He is the author of several recent patents and publications and numerous presentations at medical conferences around the world. He has reviewed several papers for reputed journals and authored two book chapters. He serves on the Editorial board of the Journal of Breath Research, Journal of Pharmacogenomics & Pharmacoproteomics and International Journal of Clinical Pharmacology & Toxicology.
His previous experience includes working for Ribozyme Pharmaceuticals in Boulder, CO and Monsanto in St Louis, MO. His postdoctoral research was conducted at the University of Iowa and Kings College London.